Dupuis J et al. Significant prognostic impact of [18F]fluorodeoxyglucose-PET scan performed during and at the end of treatment with R-CHOP in high-tumor mass follicular lymphoma patients: A GELA-GOELAMS study. Proc ASH 2011;Abstract 877.

Dr Gregory is the Elodia Kehm Chair of Hematology, Professor of Medicine and Director of the Hematology Section at Rush University Medical Center in Chicago, Illinois.

Dr Kahl is Associate Professor and Director of the Lymphoma Service at the University of Wisconsin School of Medicine and Public Health and Director for Clinical Research at UW Carbone Cancer Center in Madison, Wisconsin.